Nearly six years after canceling IPO, Gelesis goes public via SPAC
For the second time in six years, weight loss-focused company Gelesis Inc. has eschewed the IPO route. But this time, it's still planning to go public — just via a merger with a special-purpose acquisition company, or SPAC, in a deal that values the company at $1.3 billion.
Gelesis had originally planned become publicly traded through a traditional IPO back in 2015. Then, days before its scheduled offering, the company withdrew, instead opting to raise $31.5 million via private investors.
Now,…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Rowan Walrath Source Type: news